News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
611,691 Results
Type
Article (45392)
Company Profile (155)
Press Release (566144)
Multimedia
Podcasts (36)
Webinars (10)
Section
Business (170819)
Career Advice (2554)
Deals (31108)
Drug Delivery (90)
Drug Development (75635)
Employer Resources (146)
FDA (16154)
Job Trends (13306)
News (301638)
Policy (29979)
Tag
Academia (2571)
Academic (1)
Accelerated approval (6)
Adcomms (27)
Allergies (82)
Alliances (46183)
ALS (92)
Alzheimer's disease (1371)
Antibody-drug conjugate (ADC) (118)
Approvals (16134)
Artificial intelligence (247)
Autoimmune disease (24)
Automation (13)
Bankruptcy (337)
Best Places to Work (10599)
BIOSECURE Act (20)
Biosimilars (99)
Biotechnology (123)
Bladder cancer (75)
Brain cancer (29)
Breast cancer (276)
Cancer (2230)
Cardiovascular disease (162)
Career advice (2144)
Career pathing (30)
CAR-T (154)
Cell therapy (433)
Cervical cancer (18)
Clinical research (61713)
Collaboration (818)
Company closure (1)
Compensation (307)
Complete response letters (24)
COVID-19 (2437)
CRISPR (41)
C-suite (241)
Cystic fibrosis (101)
Data (2160)
Denatured (12)
Depression (47)
Diabetes (255)
Diagnostics (5743)
Digital health (18)
Diversity (4)
Diversity, equity & inclusion (34)
Drug discovery (126)
Drug pricing (100)
Drug shortages (23)
Duchenne muscular dystrophy (93)
Earnings (64138)
Editorial (40)
Employer branding (17)
Employer resources (128)
Events (84441)
Executive appointments (725)
FDA (17425)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (8)
Funding (738)
Gene editing (101)
Generative AI (22)
Gene therapy (309)
GLP-1 (651)
Government (3896)
Grass and pollen (5)
Guidances (72)
Healthcare (16623)
Huntington's disease (21)
IgA nephropathy (27)
Immunology and inflammation (111)
Indications (28)
Infectious disease (2582)
Inflammatory bowel disease (134)
Inflation Reduction Act (7)
Influenza (49)
Intellectual property (100)
Interviews (480)
IPO (14406)
IRA (36)
Job creations (3120)
Job search strategy (1778)
Kidney cancer (11)
Labor market (29)
Layoffs (373)
Leadership (21)
Legal (6525)
Liver cancer (75)
Lung cancer (309)
Lymphoma (147)
Machine learning (7)
Management (50)
Manufacturing (286)
MASH (62)
Medical device (11385)
Medtech (11388)
Mergers & acquisitions (17215)
Metabolic disorders (641)
Multiple sclerosis (85)
NASH (17)
Neurodegenerative disease (97)
Neuropsychiatric disorders (23)
Neuroscience (1918)
NextGen: Class of 2025 (5837)
Non-profit (4323)
Now hiring (20)
Obesity (330)
Opinion (235)
Ovarian cancer (73)
Pain (90)
Pancreatic cancer (81)
Parkinson's disease (149)
Partnered (22)
Patents (234)
Patient recruitment (114)
Peanut (44)
People (51375)
Pharmaceutical (34)
Pharmacy benefit managers (15)
Phase I (19375)
Phase II (27286)
Phase III (20214)
Pipeline (1172)
Policy (132)
Postmarket research (2142)
Preclinical (8147)
Press Release (61)
Prostate cancer (102)
Psychedelics (32)
Radiopharmaceuticals (242)
Rare diseases (380)
Real estate (4949)
Recruiting (64)
Regulatory (21633)
Reports (30)
Research institute (2452)
Resumes & cover letters (424)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (74)
Series A (121)
Series B (82)
Service/supplier (5)
Sickle cell disease (48)
Special edition (14)
Spinal muscular atrophy (148)
Sponsored (27)
Startups (3239)
State (2)
Stomach cancer (10)
Supply chain (62)
Tariffs (32)
The Weekly (23)
Vaccines (671)
Venture capitalists (36)
Weight loss (214)
Women's health (30)
Worklife (17)
Date
Today (142)
Last 7 days (809)
Last 30 days (2379)
Last 365 days (30392)
2025 (10161)
2024 (32523)
2023 (36533)
2022 (46923)
2021 (50721)
2020 (49128)
2019 (42061)
2018 (31986)
2017 (29753)
2016 (28443)
2015 (33059)
2014 (25843)
2013 (21858)
2012 (23368)
2011 (24060)
2010 (22575)
Location
Africa (788)
Alabama (50)
Alaska (6)
Arizona (156)
Arkansas (13)
Asia (37769)
Australia (6509)
California (5512)
Canada (1912)
China (507)
Colorado (244)
Connecticut (271)
Delaware (125)
Europe (82883)
Florida (847)
Georgia (170)
Idaho (52)
Illinois (513)
India (23)
Indiana (288)
Iowa (8)
Japan (159)
Kansas (97)
Kentucky (20)
Louisiana (10)
Maine (64)
Maryland (792)
Massachusetts (4058)
Michigan (204)
Minnesota (315)
Mississippi (2)
Missouri (81)
Montana (31)
Nebraska (24)
Nevada (59)
New Hampshire (60)
New Jersey (1626)
New Mexico (26)
New York (1657)
North Carolina (895)
North Dakota (9)
Northern California (2392)
Ohio (195)
Oklahoma (15)
Oregon (33)
Pennsylvania (1232)
Puerto Rico (13)
Rhode Island (27)
South America (1104)
South Carolina (23)
South Dakota (1)
Southern California (2114)
Tennessee (91)
Texas (864)
United States (21011)
Utah (171)
Virginia (139)
Washington D.C. (58)
Washington State (526)
West Virginia (2)
Wisconsin (48)
611,691 Results for "flanders institute for biotechnology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
LIXTE Biotechnology Holdings to Collaborate with Roche and Netherlands Cancer Institute in New Colon Cancer Clinical Trial
LIXTE Biotechnology Holdings, Inc., a clinical stage pharmaceutical company, announced a collaboration with Roche and the Netherlands Cancer Institute to conduct a new clinical trial in immune therapy unresponsive metastatic colon cancer.
June 14, 2024
·
4 min read
Press Releases
New tool for cutting DNA: promising prospects for biotechnology
April 15, 2025
·
4 min read
Press Releases
UNITY Biotechnology to Present at the ARVO 2025 Annual Meeting
May 2, 2025
·
3 min read
Press Releases
Boston Institute of Biotechnology, LLC with BiBo Pharma Announce Groundbreaking Expansion to Revolutionize Global Biologics Production Capacity
December 20, 2024
·
3 min read
Press Releases
Puma Biotechnology Presents Clinical Data on Neratinib at the AACR Annual Meeting 2025
April 28, 2025
·
6 min read
Press Releases
Spiderwort Biotechnologies Inc. Announces Status of Biocompatibility Testing for CelluJuve®
April 30, 2025
·
3 min read
Press Releases
Adaptive Biotechnologies Reports First Quarter 2025 Financial Results
May 1, 2025
·
13 min read
Press Releases
Aspire Biopharma Holdings, Inc., Announces Institutional Review Board Approval for In-Human Clinical Trial of an Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation
April 30, 2025
·
5 min read
Press Releases
Nautilus Biotechnology Reports First Quarter 2025 Financial Results
April 30, 2025
·
8 min read
Press Releases
Genezen and Optieum Biotechnologies Partner to Support cGMP Manufacturing of Groundbreaking CAR-T Therapy for Glioblastoma
May 5, 2025
·
3 min read
1 of 61,170
Next
